Hepatocyte nuclear factor 1 (HNF-1) is a transcriptional regulatory protein possibly involved in the activation of many liver-specifically expressed genes. HNF-1 mRNA is restricted to a small number of tissues, suggesting that the HNF-1 gene itself is regulated at the transcriptional level. We have isolated and characterized the promoter region of this gene and have determined its transcriptional potential in several cell types by cell-free transcription and transient transfection experiments. In in vitro transcription assays, an HNF-1 promoter is active in nuclear extracts from liver and kidney, two tissues that contain HNF-1, but silent in nuclear extracts from spleen and lung, which are devoid of this transcription factor. Likewise, in transfection experiments, HNF-1 promoter-chloramphenicol acetyltransferase (CAT) fusion genes are expressed in Hep G2 cells, which express HNF-1, but not in mouse L cells or Hela cells, which do not express HNF-1. In both cell-free transcription and transient transfection assays, a relatively short promoter segment located between positions -82 and -40 is necessary and sufficient to direct cell type-specific HNF-1 transcription. This region contains a single site for a DNA-binding protein that has been tentatively identified as hepatocyte nuclear factor 4, a member of the steroid hormone receptor family.
During the development of complex multicellular organisms, certain genes become activated in a highly cell type-specific manner. At least in part, this selective induction of gene activity is governed by transcriptional regulatory proteins that are themselves tissue-specifically regulated (for review, see Maniatis et al. 1987; Ingham 1988; Falvey and Schibler 1990) . One such transcription factor is hepatocyte nuclear factor 1 (HNF-1), a transcriptional activator protein enriched in parenchymal hepatocytes. High-affinity binding sites for this protein have been identified in the control regions of several liver-specifically expressed genes (for review, see Crabtree et al. 1991) . These include the ones encoding c~-and f~-fibrinogen (Gourtois et al. 1987; 1988) , ~-fetoprotein (Courtois et al. 1988; Jose-Estanyol et al. 1989) , albumin (Courtois et al. 1988; Lichtsteiner and Schibler 1989) , transthyretin (Costa et al. 1989 ), a-l-antitrypsin (Courtois et al. 1988; Monaci et al. 1988) , and pyruvate kinase (Vaulont et al. 1989a, b) .
Complementary DNAs for HNF-1 have been isolated by molecular cloning techniques in several laboratories (Frain et al. 1989; Baumhueter et al. 1990; Chouard et al. 1990 ). Sequence analysis of recombinant HNF-1 DNAs revealed that HNF-1 is a distantly related member of the POU-homeo box family. This protein binds DNA as a dimer via an atypical helix-turn-helix motif and dimerizes via a short c~-helical amino-terminal segment (Chouard et al. 1990; Nicosia et al. 1990 ). In cotransfection (Nicosia et al. 1990 ) and cell-free transcription experiments (Frain et al. 1989; Lichtsteiner and Schibler 1989) , HNF-1 efficiently trans-activates the transcription of reporter genes carrying appropriate recognition sequences in their promoters. HNF-1, like the products of its putative target genes, accumulates only in a small number of cell types (see Crabtree et al. 1991 and references therein) . Likewise, significant levels of HNF-1 mRNA are only detectable in a restricted number of cell types, such as parenchymal hepatocytes and kidney cells, but not in other tissues such as spleen, lung, and brain (Frain et al. 1989; Baumhueter et al. 1990 ; Xanthopoulos et al. 1991) . The question now arises how the expression of the HNF-1 gene itself is tissue-specifically regulated.
In this paper we describe the isolation and functional characterization of a DNA region encompassing the HNF-1 promoter. Both in vivo and in vitro analysis identified a cis-acting element located upstream of the TATA box, which appears to have a crucial role in the cell typespecific transcription of the HNF-1 gene. This element is a high-affinity-binding site for another hepatocyte-enriched transcription factor, hepatocyte nuclear factor 4 (HNF-4) (Sladek et al. 1990 ).
R e s u l t s

Isolation of the HNF-1 promoter region
The nucleotide sequence of nearly full-length cDNAs for HNF-1 has recently been reported by several groups (see above). A double-stranded D N A fragment spanning the 5'-proximal 55-nucleotide cDNA sequence (Frain et al. 1989 ) was used as a probe to screen a genomic rat DNA library by hybridization. Two recombinant phage plaques yielding positive signals were purified, and their D N A was isolated. A restriction cleavage site analysis of this D N A revealed two overlapping recombinant phage inserts that share -5 kb of sequences and, together, span a region of -3 5 kb. As suggested by Southern blot analysis, both of these recombinant DNAs contain an --655-bp SmaI-SacI fragment that hybridizes to the 55-bp probe used in the screening. This fragment was subcloned into a plasmid vector (pBS +) and was positively identified as part of the HNF-1 gene by a partial nucleotide sequence analysis. The 186 nucleotides adjacent to the SacI site were identical with the corresponding cDNA region upstream of the SacI site (Frain et al. 1989 ).
The tentative transcriptional start site was determined by an $1 nuclease experiment with RNAs from liver, kidney, lung, and spleen and a quasi-end-labeled singlestranded D N A probe spanning the putative HNF-1 promoter region. The S1 nuclease-resistant fragments were size fractionated by denaturing polyacrylamide gel electrophoresis alongside the four dideoxy sequencing reactions obtained by primer extension on the same singlestranded D N A that was used as a template for the production of the D N A probe. As shown in Figure 1A , two bands of -2 5 0 nucleotides are observed with liver and kidney RNA but not with spleen, lung, and yeast RNA. On the basis of this experiment we tentatively determined the start site on the HNF-1 promoter sequence as indicated in Figure lB . Figure 1B displays the nucleotide sequence between position -2 5 0 and + 100. As expected, a TATA box-like sequence, GATAAATA, is located between 23 and 30 nucleotides upstream of the transcriptional start site.
Tissue-specific transcription from the HNF-1 promoter
The cell-free transcription system developed by Gorski   B   GAAGGCATC TTGGGCAGTG GGACCAGCGC TGCTCCCAGA GGCCTCCTGG CTCCTGGTGC  -191   CTCTCTCCCT GCGCCCCTGG TTCCCGCTCC ACCTCCCCCA CCCGCCCTTC TGCTCACTCC  -131   CAATTGCAAG CCATGGCTCC CGGTCCGGTC CCTCTCGCTG CTGTGAGGCC TGCACTTGCA  -71 AGGCTGAAGT CCAAAGTTCA GTCCCTTCGC TAAGCACACG IGATAAATA~G AACCTTGGAG -ii TRHE AATTTCCCCA GCTCCAATGT AAACAGAGCA GGCAGGGGCC CTGATTCACT AGCCGCTGGG 50 GCCAGGGTTG GGGGTTGGGG GTGCCCACAG GGCTTGACTA GTGGGATTTG Figure 1 . The HNF-1 transcription start site. (A) S1 nuclease mapping of HNF-1 transcripts. $1 nuclease-protected DNA fragments obtained by hybridization of a single-stranded HNF-1 DNA probe (-401/+ 255) with 200 ~g each of RNA from liver, kidney, spleen, lung, and yeast were separated alongside the four sequencing reactions. These were obtained by extension of the primer used in the preparation of the S 1 nuclease DNA probe in the presence of dideoxynucleotides and [a-32P]dATP. The strong signal migrating more slowly than the 517-nucleotide marker probably represents some self-protection of the DNA probe by contaminating plus strand. (B) Nucleotide sequence around the transcriptional start site of the HNF-1 promoter. Both strands were sequenced according to t h e dideoxy chain-termination procedure of Sanger et al. (1977) . The putative position of the transcriptional start site, as deduced from the S1 nuclease mapping described above, is indicated by an arrow. An A-rich TATA box-like sequence, located upstream of the transcription initiation site, is framed. The underlined nucleotide region was strongly protected from DNase I digestion in the presence of liver nuclear proteins. The DNA segment underlined with a dotted line corresponds to a partial DNase I footprint observed only with high concentrations of nuclear proteins (see Fig. 5 ). et al. (1986) has proven valuable in the rapid identification of important cis-acting promoter elements and trans-acting factors possibly involved in the tissue-specific expression of the serum albumin gene (Maire et al. 1988; Lichtsteiner and Schibler 1989; Descombes et al. 1990; Mueller et al. 1990; Wuarin et al. 1990 ). Therefore, we decided to examine whether cell type-specific HNF-1 transcription can also be mimicked in vitro. In pilot experiments we adapted the cell-free transcription assays to additional tissues, such as kidney and lung, which had not been used previously in such studies. As a result of their high content in proteases, these tissues have been a poor source for transcriptionally active nuclear extracts. However, by performing the initial tissue homogenization in a cocktail containing 1% low-fat milk (Maire et al. 1989) , this problem could be overcome, such that nuclear extracts with a similar transcriptional potential can now be routinely obtained from liver, spleen, lung, and kidney (see below). These four tissues were chosen because they include two expressing and two nonexpressing tissues with regard to HNF-1 mRNA.
To construct a reporter gene for cell-free transcription assays, an HNF-1 promoter region spanning -4 0 0 nucleotides ( -4 0 1 to + 1) was inserted into a plasmid vector upstream of a 380-bp G-free cassette (Sawadogo and Roeder 1985) . This template, together with the plasmid AdML(190), carrying the adenovirus major late promoter fused to a 190-bp G-free cassette (Lichtsteiner and Schibler 1989; Maire et al. 1989) , was incubated in nuclear extracts from liver, kidney, spleen, and lung. As shown in Figure 2 , the HNF-1 promoter is utilized efficiently in liver and kidney nuclear extracts but is silent in lung and spleen extracts. As strong transcription signals are observed for the adenovirus major late promoter with nuclear extracts from all four tissue sources, the differential in vitro transcription from the HNF-1 promoter is not attributable merely to a different quality of Figure 2 . Tissue-specific in vitro transcription from the HNF-1 promoter. Equimolar mixtures of two G-free cassette plasmids (800 ng each), carrying either the HNF-1 promoter (HNF-1) or the adenovirus major late (AdML) promoter, were incubated for in vitro transcription with nuclear extracts prepared from liver, kidney, spleen, and lung. The lengths of HNF-1 and adenovirus major late promoter in vitro transcripts are 380 and 190 nucleotides, respectively. To further define the cis-acting elements responsible for tissue-specific HNF-1 in vitro transcription, promoter sequences were progressively deleted in a 5' ---~3' direction and the resulting m u t a n t plasmids were assayed for transcriptional activity in a liver nuclear extract. As shown in Figure 3 , sequences upstream of position -82 have little, if any, influence on the amplitude of in vitro transcription. However, further deletion of sequences down to position -4 0 results in a significant decrease in the transcription signal. Therefore, sequences located between -82 and -40 appear to be necessary and sufficient for in vitro transcription from the HNF-1 promoter.
To examine the validity of the in vitro transcription experiments, the efficiencies of progressively deleted HNF-1 promoters were also measured in living cells. To this end, HNF-l-chloramphenicol acetyltransferase (CAT) fusion plasmids were transfected into h u m a n HepG2 cells, which express their endogenous HNF-1 gene, or h u m a n Hela cells and mouse LTK-cells, which do not express their endogenous HNF-1 gene. Two days after transfection the CAT activity was determined in lysates of transfected cells. Figure 4A demonstrates that all fusion gene constructs carrying HNF-1 5'-flanking sequences >182 nucleotides give rise to measurable CAT activities in cells of hepatic origin (HepG2). In keeping with the in vitro results described above, a further deletion to -4 0 strongly attenuates the transcriptional activity of the HNF-1 promoter. No significant CAT activities could be measured in extracts from transfected LTK cells (Fig. 4B} or HeLa cells (Fig. 4C} . In contrast, similar CAT activities were obtained for all three cell lines transfected with pSV-CAT (see lane 1 in Fig. 4A ,B,C), a plasmid from which CAT m R N A transcription is driven by an SV40 viral promoter, suggesting that the differential expression of the HNF-1-CAT fusion genes cannot be accounted for by a differential transfection efficiency.
In conclusion, the experiments described in this section suggest that a relatively short promoter segment, Figure 5 . DNase I protection analysis of an HNF-1 promoter fragment with liver nuclear extract. An end-labeled DNA fragment encompassing the transcriptional start site (+ 1) was incubated in 20-~1 reactions with liver nuclear proteins {amounts indicated at top of lanes) before partial digestion with DNAse I. The digestion products were size fractionated alongside T + C and G + A Maxam-Gilbert degradation products of the same end-labeled fragment by electrophoresis on a 5% denaturing polyacrylamide gel. The precise boundaries of the TRH footprint were determined in a similar experiment with a fragment end-labeled at position -119 (data not shown). The nature of the protein responsible for the partial footprint centered around -190 is unknown. located between -82 and -40, plays an essential role for the cell type-specific transcription of HNF-1, both in cell-free transcription and transient transfection experiments. 
A single promoter element is required for cell type-specific in vitro transcription
Promoter and/or enhancer elements usually stimulate transcription by binding sequence-specific positively acting transcription factors. To screen the HNF-1 promoter region for the presence of binding sites for putative trans-activator proteins, DNase I protection studies were performed with transcriptionally active liver nuclear extracts. As shown in Figure 5 , at moderate protein concentrations (up to 9 ~g/20 ~1) a single DNase I-resistant region ( -4 8 to -69) can be discerned within an end-labeled HNF-1 promoter fragment. This region, the boundaries of which are shown in Figure 1B , was named TRH (for transcriptional regulatory element of HNF-1). At higher inputs of liver nuclear extracts, an additional weak footprint centered around -1 9 0 is observed. Because we could not attribute a clear functional significance to this promoter segment ( -2 6 7 to -119, see Fig.  3 and 4) on the basis of our cell-free transcription and transfection studies, we did not undertake any further attempts to characterize this weak binding site in greater detail.
To examine the possible involvement of TRH in the enhancement of transcription from the HNF-1 promoter, a double-stranded oligonucleotide encompassing this D N A element was synthesized and used as a competitor in cell-free transcription assays with liver nuclear extracts (Fig. 6 ). The addition of synthetic TRH oligonucleotide reduces in vitro transcription from an HNF-1 promoter containing this binding site Fig. 6 , lanes 1-3) to the basal level observed with an HNF-1 promoter lacking TRH ( -4 0 ; Fig. 6, lanes 4--6 ). Inhibition is specific, as the same concentration of another doublestranded oligonucleotide, the albumin promoter element B, does not affect in vitro transcription from the HNF-1 promoter (Fig. 6, lanes 7-12) . Incidentally, this control oligonucleotide is a high-affinity binding site for HNF-1 itself. The failure of this D N A fragment to interfere with HNF-1 transcription suggests that, at least in our simple assay system, HNF-1 does not activate its own transcription via an autoregulatory circuit. More likely, another transcriptional activator, the tentative identification of which will be described below, appears to control HNF-1 transcription in vitro and, by inference from the sequence requirement, in vivo.
TRH is the only cis-acting regulatory element within the HNF-1 promoter for which we were able to demonstrate a clear-cut enhancing effect in cell-free transcription and transient transfection. Therefore, this element should also account for the cell type specificity of HNF-1 transcription. According to the most straightforward prediction, the TRH cognate factor would be expected to accumulate at higher levels in HNF-1-expressing tissues, such as liver and kidney, than in nonexpressing tissues, such as spleen and lung. This simple hypothesis was examined by electrophoretic mobility-shift assays, with the double-stranded TRH oligonucleotide as a labeled D N A probe. As shown in Figure 7 , specific p r o t e i n -D N A complexes with identical mobilities can be discerned with nuclear liver and kidney but not with lung and spleen nuclear extracts (Fig. 7, lanes 1-8) . This does not merely reflect an inferior quality of the latter two extracts, as these extracts are similarly competent with regard to in vitro transcription from the adenovirus major late promoter as the former two extracts (Fig. 2A) . Moreover, all four extracts contain comparable amounts of undergraded NF-Y, a ubiquitous CCAAT-binding fac-tot with affinity to the albumin promoter element C (Fig.  7, lanes 10--12) .
Identification of the TRH-binding factor
Inspection of the TRH sequence reveals striking similarity (10 of 12) with the consensus sequence for HNF-4 proposed by Sladek et al. (1990) . Moreover, the tissue distribution of HNF-4 m R N A correlates well with the nuclear factor binding to the TRH element within the H N F -1 promoter, in that it accumulates in liver and kidney but not in spleen and lung (Sladek et al. 1990 ). In a mobility-shift assay with crude liver nuclear extract, complexes with similar mobilities are formed with double-stranded oligonucleotides APF-1, which encompasses a bona fide HNF-4 recognition sequence [from the apolipoprotein CII (apoCIII) gene promoter], and TRH (Fig. 8A) . It appeared feasible, therefore, that TRH would be a recognition sequence for HNF-4. In keeping with this hypothesis, unlabeled TRH or APF-1 oligonucleotides compete similarly well for binding to the radiolabeled TRH and APF-1 D N A probes. In contrast, a well characterized HNF-3-binding site derived from the transthyretin promoter does not interfere with the formation of protein-TRH or protein-APF-1 complexes. To examine further the similarity between HNF-4 and the TRH-binding protein, the latter protein was partially purified by heparin-agarose chromatography, followed by DNA-Sepharose affinity chromatography (twice successively) on a resin carrying covalently linked multimerized TRH elements. The protein was then photo-cross-linked to its radio-labeled TRH-binding site and size-fractionated by SDS-PAGE. As shown in Figure 8B , the cross-linked protein-DNA complex migrates at 56 kD, consistent with the apparent molecular mass of 54 kD for HNF-4 as measured by Sladek et al. (1990) . When cross-linking is performed in the presence of a large excess of unlabeled TRH oligonucleotide, the labeled protein-DNA complex can no longer be observed.
Finally, we examined whether the TRH-binding protein is immunologically related to HNF-4. To this end, electrophoretic mobility-shift assays were performed in the presence of a polyclonal HNF-4 antiserum (generously provided by F. Sladek and J. Darnell} by using liver nuclear extracts incubated with the TRH oligonucleotide. As shown in Figure 8C , a large proportion of the protein-TRH complex reacts with HNF-4 antibodies, giving rise to two additional complexes with lower mobilities.
In conclusion, the TRH-binding protein and HNF-4 share DNA-binding specificity, size, and immunologically detectable epitopes. Together, these findings strongly suggest that the two proteins are identical. Sladek et al. 1990) were end labeled and used as probes in electrophoretic mobility-shift assays with liver nuclear extract. The same oligonucleotides and an oligonucleotide containing an HNF-3 recognition sequence from the transthyretin promoter ) were used as competitors (indicated at top). (B) UV cross-linking of affinity-purified TRH-binding protein with its radiolabeled recognition sequence in the absence ( -) and presence ( + ) of unlabeled binding site. The predominant radiolabeled protein-DNA complex migrates with an apparent molecular mass of 56 kD. (C) Immunological reactivity of the TRH-binding protein with HNF-4 antiserum. Electrophoretic mobility-shift assays with liver nuclear extracts and radiolabeled TRH oligonucleotide were performed in the absence or presence of HNF-4 antiserum. Five microliters of a 'Aoo dilution of the antiserum was used in a final reaction volume of 20~1. The antiserum was diluted in PBS containing 3% BSA. As a control for binding specificity, protein-DNA complex formation was inhibited by the addition of unlabeled competitor TRH oligonucleotide.
HNF-1, a gene specifying a protein thought to be involved in the transcriptional regulation of many liverspecifically expressed genes, is itself expressed in only a subset of cell types (Frain et al. 1989; Kuo et al. 1990; Xanthopoulos et al. 19911 . To elucidate the molecular basis for this tissue-specific expression, genomic clones encompassing the HNF-1 promoter have been isolated and functionally characterized by cell-free transcription and transient transfection experiments. In both assay systems, a relatively short DNA segment located between -82 and -40 can direct cell type-specific transcription from the HNF-1 promoter. In vitro, G-free cassette reporter genes carrying this element yield transcripts in nuclear extracts from liver and kidney but are silent in spleen and lung nuclear extracts. Likewise, transfected HNF-1 promoter-CAT fusion genes containing this element are active in HepG2 hepatoma cells but inactive in LTK-cells or HeLa cells. In all of these situations there is a perfect correlation between the expression of the endogenous HNF-1 gene, at least with regard to the production of functional mRNA and protein (see below), and the exogenously added reporter genes driven by the HNF-1 promoter. The promoter segment (-82 to -40) responsible for this cell-type-specific transcription bears a single binding site (TRH) for a nuclear factor whose tissue distribution correlates with the in vivo and in vitro activity of the HNF-1 promoter. On the basis of its DNA-binding properties, size, and immunologically detectable epitopes, this nuclear factor has been identified as HNF-4. Surprisingly, in vitro-elongated nascent transcripts hybridizing to HNF-1 cDNA probes have recently been observed in spleen, a tissue that accumulates neither HNF-1 mRNA nor protein (Xanthopoulos et al. 1991) . As the 5' ends of these nascent RNA chains have not yet been mapped it remains to be determined whether they are initiated within the HNF-1 promoter region discussed in this paper.
Recently, an HNF-4 cDNA has been isolated and characterized by Sladek et al. (1990) . This transcription factor binds DNA via a zinc finger domain and appears to be a member of the steroid hormone receptor superfamily. HNF-4-binding activity and HNF-4 mRNA accumulation are restricted to a small number of tissues, including liver, kidney, and intestine. In liver, HNF-4 may be required for efficient transcription of the genes encoding transthyretin, apoCIII, and Rl-antitrypsin (for references, see Sladek et al. 1990 ). These three putative HNF-4 target genes all produce abundant proteins that fulfill important liver functions in the differentiated organism. As suggested by the experiments described in this paper, HNF-4 may also be a crucial regulatory protein for the expression of a gene specifying another liver-enriched transcriptional activator, HNF-1. Interestingly, HNF-1 and HNF-4 appear to cooperate in the transcriptional activation of several liver-specific genes, including ~l-antitrypsin (Monaci et al. 1988; Costa et al. 1989; Sladek et al. 1990 ) and transthyretin (Costa et al. 1989 ). This exemplifies the complex regulatory circuitry involved in the control of tissue-specific gene transcription. A cell type-enriched transcription factor may orchestrate the coordinated accumulation of another cell type-enriched regulatory protein. The two transcription factors may then efficiently activate transcription of downstream genes by a synergistic action.
The transcriptional regulation of several genes encoding tissue-specific transcription factors accumulating in nonhepatic tissues has been studied. These include Pit-1-GHF-1, a pituitary gland-specific POU homeo-domain protein (Chen et al. 1990; McCormick et al. 1990 ), a MyoD-related family of muscle-specific helix-loop-helix proteins (for review, see Olson 19901 , and the erythroid factor GATA-1 (Tsai et al. 1991) . In all of these cases, the transcription factor can apparently autoregulate its own expression by binding to the promoter of its own gene. The obvious advantage of autoregulation is that it assures the maintenance of factor expression, once induced. Thus far, there is no evidence for a similar autoregulation for HNF-1 expression, as no binding site for HNF-1 could be identified within the proximal promoter region directing cell type-specific expression. Nevertheless, our results cannot exclude that in the intact animal, HNF-1 participates in its own transcriptional control via remote upstream or downstream cisacting elements not yet characterized in this study.
The architecture of the HNF-1 promoter, as revealed by protein-binding studies with unfractionated liver nuclear extract, looks pleasingly simple. The only binding site occupied at low-to-moderate protein input is TRH, a high-affinity HNF-4-binding site. In contrast, the promoters of HNF-1 target genes, such as the ones encoding albumin or ~-fetoprotein, contain a series of closely spaced binding sites for a bewildering variety of different sequence-specific transcription factors (for review, see Crabtree et al. 1991) . Conceptually, this difference in complexity would be expected for promoters directing the production of rare regulatory proteins and abundant proteins. At least in part, the transcription initiation frequency at a given promoter depends on the number of cis-acting elements it contains.
Materials and methods
Selection of rat genomic clones containing the HNF-1 promoter region
About 106 recombinant phage plaques of an amplified EMBL-3-rat DNA genomic library (generously provided by P. Maire and A. Kahn, INSERM, Paris) were screened by hybridization with a synthetic DNA fragment encompassing the 5'-proximal 55 nucleotides of nearly full-length HNF-1 cDNA (Frain et al. 1989 ). This hybridization probe was obtained by annealing the two oligonucleotides 5'-GGTGCCCACAGGGCTTGACTAG-TGGGATTTGGGGG-3' and 3'-TCACCCTAAACCCCCTCG-GTCACCCACGTCGCTCGG-5' (complementary regions underlined) and by filling in the 5' overhangs with Klenow DNA polymerase in the presence of [oL-32p] dATP (3000 Ci/mmole). Ten 15-cm petri dishes were seeded with -105 PFU each of the recombinant library and incubated overnight at 37~ Duplicate phage lifts were prepared from each dish as described in Sambrook et al. (1989) . The filters were prewashed, hybridized with ~5 x 106 cpm/filter of the denatured DNA probe, and washed according to standard procedures (Sambrook et al. 1989) . Four double-positive phage plaques were purified, and their DNA was characterized by restriction digestion with the endonucleases EcoRI, BamHI, HindIII, SacI, PstI, SphI, SalI, and combinations of these enzymes. This analysis revealed two independent and overlapping HNF-1 clones (three of the four being identical) containing ~20 = kb inserts each. Together, these two recombinant DNAs encompass ~35 kb of the HNF-1 locus.
Construction of HNF-1 promoter fusion genes for in vitro transcription and transfection studies
The G-free cassette vector p(C2AT)19 (Sawadogo and Roeder 1985) and the pCAT-0 vector were used for construction of HNF-1 promoter fusion genes in cell-free transcription experiments and transfection studies, respectively.
An EcoRI-SacI fragment containing -2 kb of 5'-flanking sequences, in addition to 186 nucleotides of 5' mRNA sequences, was subcloned into the plasmid vector pBS+. The resulting recombinant plasmid was cleaved with SpeI (+ 92), blunted by Klenow polymerase, and cleaved with XbaI. The resulting HNF-1 fragment ( -2000/+ 92) was cloned between the SmaI and XbaI sites of the CAT vector pEMBL19 +/CAT/upstream mouse sequence (UMS) (Heard et al. 1987 )(generously provided by P. Maire, Paris). This plasmid served as a source for all deletion mutants, which were constructed as follows: The above donor plasmid was cleaved with different restriction enzymes removing increasing portions of the 5'-flanking sequences of the HNF-1 promoter. After blunting the ends with T4 DNA polymerase (if necessary) the promoter-containing fragment was cleaved with SacI, which cuts in the polylinker of the pEMBL19 +/CAT/UMS vector just downstream of + 92. The resulting fragments of different lengths were inserted between the SmaI-SacI sites of the pEMBL19 +/CAT/UMS vector. The following enzymes were used for the 5'-terminal truncations: PstI {-1.6 kb), SmaI (-401), FokI (-366), DraI {267), NcoI ( -119), StuI .
For the construction of in vitro transcription templates, the G-flee cassette was excised from the parent plasmid with SacISinai, blunt-ended with T4 DNA polymerase, and inserted into various portions of HNF-1 5'-flanking sequences that contain pBS +. In all cases, the 3' end (with regard to the upper strand) of these fragments was defined by an AluI site. The following enzymes were utilized to create 5' deletions: SmaI , DraI (-267), NcoI (-119), StuI .
S1 nuclease mapping
A single-stranded, quasi-end-labeled DNA probe for S 1 nuclease mapping experiments was prepared as follows. Single-stranded plasmid DNA (containing the upper strand of the insert) was obtained by superinfection of an Escherichia coli JM 109 strain harboring a pBS + plasmid carrying the SmaI-SacI HNF-1 promoter fragment (-401/+ 255) with the helper phage M13KO7 according to the method described in Sambrook et al. (1989) . This single-stranded DNA was annealed with the oligonucleotide 3'-TCAACTCGGTCGACGTCTGCCTCGAG-5' and extended with T7 DNA polymerase (Sequenase; U.S. Biochemical) in the presence of [e~-32p] dATP, unlabeled dTTP, dGTP, dCTP, and the restriction endonuclease BamHI according to Descombes et al. (1990) . The 660-bp extension product was isolated by gel electrophoresis on a 5% urea-polyacrylamide gel and used as a single-stranded probe in an S1 nuclease mapping experiment. S1 nuclease mapping was performed as described by Sierra et al. (1990) with 200 ~m each of whole-cell RNA from kidney, liver, spleen, and lung. RNA was extracted by the guanidium thiocyanate procedure described by Clemens (1984) .
DNase I protection and electrophoretic mobility-shift experiments
An end-labeled HNF-1 promoter fragment for DNase I protection experiments was prepared as follows: A recombinant plasmid containing a DraI-SpeI fragment ( -267/+ 92) inserted into the SmaI site of the pBS + plasmid vector was cleaved at the XbaI site of the pBS + polylinker upstream of position -267, treated with calf intestine alkaline phosphatase (CIP), and phosphorylated with polynucleotide kinase in the presence of [~/-3~p]ATP. After digestion with SacI (within the pBS + polylinker downstream of position + 92), the resulting end-labeled HNF-1 promoter fragment was purified by low-melting agarose gel electrophoresis. This gel-purified DNA fragment was used as a probe in DNase I protection experiments as described by Lichtsteiner et al. (1987) , except for the protein-DNA binding period, which was reduced from 90 to 10 min.
Labeled double-stranded oligonucleotides were prepared as DNA probes for the mobility-shift experiments by annealing two synthetic oligonucleotides and by filling in the 5' overhangs with Klenow polymerase in the presence of [a-a~P]dATP. The following oligonucleotides were used:
5'-GCAAGGCT GAAGT CCAAAGTT CAGT CC-3' 3'-GACTTCAGGTTT CAAGT CAGGCGTTCC-5' APF-1 site:
5'-TCGAGCAGGTGACCTTTGCCCAGCGC-3' 3'-CGT C CACTGGAAACGGGTCGCGAGCT-5' HNF-3site:
The sequences of the oligonucleotide encompassing the APF-1 element of the apoCIII promoter (Sladek et al. 1990 ), the HNF-3-binding site of the transthyretin promoter , and the NF-Y-binding site of the albumin promoter (Lichtsteiner et al. 1987 ) have been described previously. Mobility-shift assays were performed according to Lichtsteiner et al. (1987) , except that sonicated double-stranded salmon sperm DNA, rather than poly-ld(I-C)] was used as a nonspecific competitor DNA.
Preparation of transcriptionally competent nuclear extracts
Nuclei from all tissues were purified by a single centrifugation step through concentrated sucrose as described previously (Lichtsteiner and Schibler 1989; Maire et al. 1989 ). The homogenization buffer included 1% low-fat milk as a competitive inhibitor for proteolytic enzymes. This is particularly important for protease-rich tissues such as lung and kidney. In vitro transcription assays were conducted essentially as described by Gotski et al. (1986) , except that the concentration of the chain terminator 3'-O-methyl-GTP was raised to 0.5 mM. For the quantification of transcription signals, the regions of the dried polyacrylamide gel containing the radioactive in vitro transcripts were excised and counted in Aquasol (Amersham) in a liquid scintillation counter.
Protein purification
All manipulations were performed at 0--4~ A total of 44 livers from adult male rats (Lewis) were homogenized in 2.2 liters of 2.4 M sucrose homogenization buffer according to Lichtsteiner and Schibler (1989) . Nuclei were isolated from 400-ml portions of this homogenate as described previously (Lichtsteiner and Schibler 1989) and resuspended in a total of 55 ml of nuclear lysis buffer [10 mM HEPES (pH 7.6), 100 mM KC1, 3 mM MgC12, 0.1 mM DTT, 10% glycerol, 0.1 mM PMSF, 0.1% Trasylol] by homogenization in an all-glass Dounce homogenizer. NaC1 was added to a final concentration of 0.3 M. After gentle rocking for 30 rain on ice, the nuclear lysates were centrifuged at 35,000/ rpm for 1 hr in a Ti60 rotor of a Beckman ultracentrifuge. The supernatant was dialyzed twice for 2 hr against 200 volumes of nuclear lysis buffer. Insoluble material was removed by lowspeed centrifugation, and the supernatant was kept at -70~ Soluble nuclear protein (650 mg) was recovered from 44 rats. The crude nuclear extract was loaded on a 30-ml heparin-agarose column, and the proteins were step-eluted with HEM buffer [10 mM HEPES (pH 7.6), 3 mM MgC12, 0.1 mM EDTA, 1 mM DTT, 10% glycerol, 0.1% Trasylol, 0.1 mM PMSF] containing increasing amounts of KC1 (0.1 M steps from 0.1 M tO 0.6 M). The fractions were monitored for TRH-binding activity by mobility-shift assays. The 0.4 M and 0.5 M KC1 fractions containing most of the binding activity were combined, dialyzed against HEM buffer containing 0.1 M KC1, and centrifuged at 10,000 rpm in a Sorvall HB-4 rotor to remove insoluble material. The supematant was complemented with poly dI:dC (1 ~g/ml), sonicated salmon sperm DNA (6 ~g/ml), and NP-40 (0.1% ). After an incubation for 20 min on ice, the partially purified extract was applied to a 3-ml DNA-Sepharose column (Kadonaga and Tjian 1986), prepared with multimerized TRH oligonucleotides as described by Lichtsteiner and Schibler (1989) . The proteins were step-eluted with HEM buffer containing 0.1 M increments of KC1 and 0.1% NP-40. The fractions containing most of the TRH-binding activity (0.3--0.5M KC1) were pooled and dialyzed against HEM buffer containing 0.1% of the detergent LDAO and 0.1 M KC1. After addition of sonicated salmon sperm DNA to 1.5 ~g/ml, the proteins were repurified on a 1-ml DNA-Sepharose column as described above, except that NP-40 was replaced by the detergent LDAO. This partially purified preparation still contained several protein species as revealed by silver-staining of electrophoretically separated proteins (Laemmli 1970) , one of which migrated with an apparent molecular mass of 54 kD, expected for HNF-4.
UV photo-cross-linking of protein DNA complexes
A TRH probe for photo-cross-linking was prepared as follows. The two oligonucleotides 5'-GCAAGGCTGAAGTCCAAAGTT CAGTC C-3' 3'-C AAGTCAGG-5'
were annealed, and the resulting 5' overhang was filled in with Klenow polymerase. A 20-~1 reaction contained 300 ng of the annealed oligonucleotide (225 ng of the 27-met and 75 ng of the 9-mer), l0 mM Tris-HC1 (pH 7.5), 10 mM MgC12, 50 mM NaC1, 1 m/vi DDT, 0.25 mM each of dCTP, dGTP, BrdUTP, 50 ~Ci of [a-3~p]dATP (400 Ci/mmole), and 5 units of Klenow polymerase. Incubation was for 90 rain at 16~ After the addition of dATP to 0.25 raM, the reaction was allowed to continue for another 45 min. The labeled probe was separated from unincorporated nucleotides by gel filtration on Sephadex G-50. A total of 1.5 ng of this probe was incubated with 1 ~1 of partially purified TRHbinding protein (HNF-4) in 20 ~1 containing 25 mM HEPES (pH 7.6), 10 mM MgCl~, 0.5 ~xg poly[d(I-C)], 0.5 mM DTT, 1% Trasylol, 0.7 txg/ml of pepstatin A, 0.7 ~g/ml of leupeptin, 0.1 mM benzamidine, and 100 ng of sonicated salmom sperm DNA or unlabeled and unsubstituted TRH competitor oligonucleotides. After incubation On ice for 15 min, the tubes were opened, covered with Saran Wrap (to avoid evaporation), and exposed to an inverted Brouwer UV transilluminator (310 nm) for 30 min at room temperature at a distance of 4 cm. SDS-loading buffer was then added to the samples, and protein-DNA complexes were resolved by SDS-PAGE (Laemmli 1970) .
Other methods
Conventional recombinant DNA procedures and DNA sequencing (Sanger et al. 1977; Maxam and Gilbert 1980) were carried out as described by Sambrook et al. (1989) . Calciumphosphate-mediated DNA transfections and CAT assays with extracts from transfected cells were carried out as described by Mueller et al. (1990) .
